28.00
28.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
FALCEE PLUS TAB is a dual-action migraine prophylaxis formulation combining Flunarizine 10 mg, a calcium channel blocker, and Propranolol 40 mg, a non-selective beta-blocker. It is used to effectively reduce the frequency and severity of migraine attacks by targeting both vascular and neurological components. Manufactured by BluepillExpress, this tablet is designed for consistent therapeutic performance and is available for private label and international export with full regulatory compliance.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
FALCEE PLUS TAB is an oral fixed-dose combination therapy developed to address the complex pathology of migraine by integrating two pharmacological agents with complementary mechanisms: Flunarizine 10 mg and Propranolol Hydrochloride 40 mg.
Flunarizine is a selective calcium channel blocker with proven efficacy in migraine prevention. It works by reducing cerebral vasospasm, stabilizing neuronal activity, and lowering the threshold for cortical spreading depression—a key trigger in migraines. It also possesses mild sedative and antihistaminic properties, making it especially beneficial for patients with migraine-related insomnia or anxiety.
Propranolol, a non-selective beta-adrenergic blocker, acts by decreasing the excitability of cerebral blood vessels and suppressing sympathetic nervous system overactivity, both of which are involved in migraine onset. It also contributes to lowering systemic blood pressure and preventing vasodilation associated with migraine aura.
The combination in FALCEE PLUS TAB targets both central and peripheral mechanisms in migraine pathogenesis. It reduces:
Frequency of attacks
Intensity and duration of headaches
Associated symptoms like nausea, photophobia, and aura
This makes it suitable for patients with chronic migraine, refractory migraine, or vascular headaches, and is often used as a first-line option in long-term migraine prophylaxis.
